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Abstract: Hypoxia adversely affects cells and tissues, and neuronal cells in particular have been shown to be
more susceptible to the injurious effects of hypoxia in which they may begin to die when oxygen supply is
reduced or completely eliminated. Opioid receptor agonists have been shown to elicit several central nervous
system effects, mediated via G protein-coupled receptors. The aim of this study was to study the effect of
hypoxia on G protein coupled receptor gene expression using mu opioid receptor as a case study in cortical
neuronal B50 cell lines in culture. The B50 cells were cultured in normoxia (21% O2; 5% CO2) and hypoxia
(5% O2; 5% CO2), and were treated with opioid agonists to determine their effects on hypoxia-induced changes.
Three opioid agonists {DAMGO(µ), DSLET(*) and ICI--199,441(6)}, were administered to the cells as
treatment for 48 hours after 48 hours of initial culture for a total of 96 hours of culture in hypoxic conditions
at concentrations of 10, 50 and 100 :M. The levels of G-protein coupled receptor (mu opioid) mRNAs were
assessed using RT-PCR. The results showed that hypoxia induced morphological changes in B50 cells in
hypoxia while the mu opioid RT-PCR mRNA levels showed no appreciable changes in normal, hypoxic and
treated cells. The results show that B50 neuronal cells are susceptible to damage and injurious effects of
hypoxia, as are most brain cells and the opioid agonist treatments showed there were no changes in the level
of mu opioid receptor gene expression due to hypoxia or agonist treatment in neuronal B50 cells in culture.
Key words: Hypoxia, G-protein coupled receptor, Opioid (mu) receptor, messenger RNA, reverse
transcription-PCR, opioid agonist
INTRODUCTION
Cerebral hypoxia is a condition in which there is a
decreased oxygen supply to the brain even though there is
adequate blood flow (Guyton and Hall, 2005). Neural and
brain tissues have been shown to be extremely sensitive
to oxygen deprivation and can begin to die within five
minutes   after   oxygen   supply   has   been  cut  off
(Zhang et al., 2006; Tomaselli et al., 2005). When
hypoxia lasts for longer periods of time, it can cause
coma, seizures, and even brain death. In brain death, there
is no measurable activity in the brain, although
cardiovascular functions are preserved (Dietz et al.,
2003). Hypoxia in the brain may lead  to  cell death by
apoptosis and necrosis. Tomaselli et al. (2005) have
shown that adenosine, the final metabolic product of in
the stepwise dephosphorylation of ATP, is produced and
released in the central nervous system in response to
ischaemia and hypoxia. Most mammals possess little
natural tolerance to severe hypoxia, and their excitable
cells and tissues are normally debilitated by any prolonged
exposure to hypoxic condition. The primary causes of
hypoxia-induced death in mammals are brain dysfunction
and cardiac arrhythmias due to a loss of ionic integrity of
the cell membranes (Boutilier, 2001). Ion leakage across
cell membranes occurs as a result of both intracellular and
extracellular ions drifting towards their thermodynamic
equilibrium (Rolfe and Brand, 1996; Priebe et al., 1996).
Cell death occurs when ATP production fails to meet the
energetic maintenance demands of ionic and osmotic
equilibrium. The rise in free cytosolic intracellular Ca2+
concentration results in the activation of Ca2+-dependent
phospholipases and proteases that further hasten the rate
of membrane depolarisation, leading to uncontrolled
cellular swelling and, ultimately, to cell necrosis
(Hochachka, 1986; Boutilier, 2001).
Mahura (2003) has shown that neuronal responses to
hypoxia can be acute or chronic. In the early stages,
neuronal responses to ischaemia-hypoxia are dependent
on  the  modulation of ion channels. Acute responses rely
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mainly on Oxygen-regulated ion channels which mediate
adaptive changes in neuron excitability. Energy failure, an
early consequence of hypoxia-ischaemia, causes
disruption of ionic homeostasis and accumulation of
extracellular neurotransmitters. NMDA and AMPA/
kainate receptors and Ca2+ channels contribute to
excitotoxic neuronal degeneration. Excitotoxicity leads to
increased Ca2+ influx, which can activate cytotoxic
intracellular pathways (Mahura, 2003). 
Opioid receptors are found in the central nervous
system and are classified as mu (µ), kappa (6), delta (*)
and sigma (F) opioid receptors. Opioid receptors are not
uniformly distributed in the CNS and are found at areas
concerned with pain receptors, with the highest
concentration in the cerebral cortex, followed by the
amygdala, septum, thalamus, hypothalamus, midbrain and
spinal cord (Raynor et al., 1996; Chaturvedi et al., 2000).
The mu receptor has been shown to be high in areas of
pain perception and in the medulla, especially in the area
for respiration (Reisine and Bell, 1993; Reisine and
Brownstein,   1994;   Massotte   and   Kieffer,  1998;
Hasbi et al., 2000). 
The  opioid  receptors  (mu,  delta,  and  kappa)
belong  to  the  large  family  of  GPCRs  and  have
diverse  and  important  physiological  roles
(Piestrzeniewicz et al., 2006; Rhim and Miller, 1994).
Laugwitz et al. (1993) have shown that activated delta
opioid receptors are coupled to Gi1 while activated mu
opioid receptors are coupled to Gi3 in neuroblastoma cells.
Mu opioid receptors have been shown to be activated by
mu receptor agonists and are coupled through the G"i1
and G"oA in human embryonic kidney cells (Saidak et al.,
2006). Tso and Wong (2000), have shown that both mu
and kappa opioid receptors are coupled via both Gi and Gz
in HEK 239 cells. The opioid receptors are important
targets for thousands of pharmacological agents (Hasbi et
al., 2000; Wang et al., 2007). The stimulation of these
receptors triggers analgesic effects and affects the
function of the nervous system, gastrointestinal tract and
other body systems (Piestrzeniewicz et al., 2006). The
discovery of opioid peptides including delta-selective
enkephalins, kappa-selective dynorphins, and mu-
selective endomorphins, which are endogenous ligands of
opioid receptors, initiated their structure-activity
relationship studies (Fichna et al., 2006). The aim of the
present work was to investigate the expression of opioid
(mu) receptor gene in B50 neuronal cells, to investigate
the effect of hypoxia on the expression of mu opioid
receptor gene on B50 neuronal cells and to study the
effect of mu opioid receptor agonist treatment on opioid
(mu) receptor gene in cultured B50 cells using semi
quantitative RT-PCR.
MATERIALS AND METHODS
Neuronal culture: One group of B50 neuronal cells were
cultured   and   maintained   in  a normoxic incubator
(21%O2; 5% CO2) as control group and another batch
cultured under hypoxia (5%O2; 5% CO2) as experimental
group. Cells were cultured in 12-well culture plates for 48
hours and three opioid receptor agonists were treated with
opioid agonists to determine their effects on hypoxia-
induced changes. Three opioid agonists {DAMGO(:),
DSLET(*) and ICI--199,441(6)}, and antagonists were
administered to the cells as treatment against hypoxia for
48 hours for a total of 96 hours at a concentration of 10,
50 and 100 µM. The total cellular RNA was extracted
from the cultured B50 neuronal cells using the TRIzol
reagent method (Invitrogen No 15596-026), as outlined
below. The cells were cultured at the cell culture
Laboratory of Queen Margaret University Edinburgh and
the RT-PCR was done at the Centre for Neuroscience,
University of Edinburgh United Kingdom in 2006.
Methods: The B50 cells in different experimental groups
were grown and lysed in culture plates by adding 0.5 mL
of TRIzol reagent to each well. The cells were
homogenized and incubated for 5 min at room
temperature. The homogenates were transferred to micro-
centrifuge tubes, 0.1 mL of chloroform added, the cap
secured and the tubes shaken vigorously by hand for 15
sec. The cellular mixture was incubated at room
temperature for 3 min. The mixture was then centrifuged
at 12,000 × g for 15 min at room temperature. Following
centrifugation, the mixture, separated into 3-layers namely
a lower phenol-chloroform phase (Red), a middle
interphase (Cloudy) and an upper aqueous colourless
phase.
The RNA was present at the upper aqueous
colourless phase and formed about 60% of the total
volume of the mixture and was transferred to a fresh
micro-centrifuge tube. The aqueous phase was mixed with
0.25 mL of isopropyl alcohol and incubated for 10 min at
room temperature. The mixture was then centrifuged at
12,000 × g for 10 min at room temperature. At this point
the RNA precipitated and formed a gel-like pellet.
The supernatant was removed and the remaining
RNA pellet was washed once with 0.5 mL of 75% ethanol
and mixed by vortexing. The mixture was centrifuged at
7,500 × g for 5 min at room temperature and the ethanol
was decanted. The RNA was then air dried for 10 min,
dissolved in 100% deionized formamide and stored at -
70ºC to be used in RT-PCR analysis.
Semi-quantitative one step RT-PCR analysis: The
semi-quantitative one step reverse transcriptase
polymerase chain reaction (RT-PCR) was used to study
the expression of mu opioid receptors. Mu Opioid
Receptor (MOR) was selected for the semi-quantitative
RT-PCR analysis because the MOR was selected for
study because opioid receptor subtypes have been shown
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to have 68% sequence homology between them and the
differences between them was proposed largely, on the
basis of radioligand binding studies and as such there is
little   or   no   evidence  for  the  presence  of  the
different genes encoding the opioid receptor subtypes
(Corbett et al., 2006). In some cases receptor
heterodimerisation of opioid receptors has been proposed
as a possible explanation for the different opioid receptor
subtypes (Corbett et al., 2006; Milligan, 2004).
The extracted total RNA, Superscript III RT/Platinum
Taq Mix, Reaction Mix, 5 nM Magnesium Sulphate,
GeneAMP PCR System thermal cycler were used
according to the manufacturer’s instruction. Mu Opioid
Receptor (MOR) sense primers, 5-GGA ACA TGG CCC
TTC GGA ACC ATC-3' (574-597) and antisense 5'-TAC
CAG GTT GGG TGG GAG AAC GTG-3' (863-840),
were selected from Silbert et al. (2003), where they were
used to study the effect of MOR expression and opioid
treatment  in  myelinated  and unmyelinated neurons.
Alpha actin primer Sense  5’-GAT CAC CAT CGG GAA
TGA ACG C-3’  (389bp) and Antisense 5’-CTT AGA
AGC   ATT   TGC   GGT  GGA  C-3’,  selected  from
Park et al. (1997), where they were used as an internal
control for cytoskeletonal study in pericytes.
Programming of the thermal cycler was done as
follows:  cDNA synthesis 1 cycle at 55ºC for 30 min,
Denaturation 1 cycle at 94ºC for 2 min, PCR
amplification 40 cycles at 94ºC for 15 sec (Denature),
60ºC for 30 sec (Anneal), 68ºC for 60 sec (Extend), Final
extension, 1 cycle at 68ºC for 5 min. 
The master mix was prepared on ice using 0.2 mL
nuclease free, thin walled PCR tubes. Each PCR tube
contained the following: 2 x Reaction mix (dNTPs:
200:M; MgSO4:1.6mM) 25:L, Template RNA (200
ng/:L) 1:l, Sense Primer (0.2:M), 1 :L, Antisense
Primer (0.2:M)1:L, SuperScript III RT/ Platinum Taq
mix (5 mM) 2:L, Autoclaved distilled water; 20 :L was
added to make up total volume to 50 :L.
These were mixed together gently and all the
components were allowed to settle at the bottom of the
amplification tube. The tubes were then centrifuged
briefly by pulse centrifugation, over-laid with one drop of
mineral oil and placed in a preheated thermal cycler
(GeneAMP PCR System) as programmed above. One
tube was used as blank and contained only master mix
and water.
Analysis of the RT-PCR products: The analysis of the
PCR products was carried out using the following
method. Agarose gel (2%) was made by dissolving 2.5 g
agarose in 112.5 mL of distilled water which was
subsequently micro-waved in a conical flask for 5 min.
12.5 mL buffer solution of Tris/Borate/EDTA (TBE) was
added and 5 :L of ethidium bromide added for staining
the mRNA and mixed thoroughly. The mixture was
poured into the gel tray with combs in place and air
bubbles pushed to the sides with a pipette. The gel was
allowed 1 h to set. 5 :L of Blue loading buffer (Sigma,
G7654), which contain bromphenol blue (0.25% w/v),
xylene cyanole FF (0.25% w/v), sucrose (40% w/v), was
added to each of the samples and centrifuged briefly to
mix and settle. 
A 10 :L DNA ladder (Promega, G2101) and 5 :L
Blue loading buffer was used to make-up the DNA
marker, and one litre of gel buffer was made using the
TBE in a 1:10 dilution. The gel was placed in an
electrophoresis tank with wells at the negative electrode
such that RNA will move towards the positive electrode.
The  gel was then surrounded with gel buffer and the
wells completely covered by the buffer. The DNA marker
(5 :L), was added to the gel on position one, followed by
adding a 10 :L blank sample to the next position, and
continuing to add 10 :L of each sample to the remaining
wells. The electrophoresis tank was connected to a power
supply set at 125V for one hour. Photographs of the gels
were taken and scanned using the digital densitometer to
evaluate and semi-quantify the mRNA of the receptors,
and then compared between the different groups.
Statistical analysis: The different parameters measured
from the normal, hypoxic and treated experimental groups
of B50 neuronal cells were compared using mean and
standard deviation (SD). The parameters were assayed in
triplicate and repeated twice (n = 6) and the results
presented as the mean ±SD. The Students’t-test was used
for testing the level of significance between two groups
and a p-value less than 0.05 was considered to be
significant using Microsoft Excel® package. For multiple
treatment data, One-Way Analysis of Variance (ANOVA)
was used followed by Multiple Range Test post hoc
subgroup testing to find the Least Significant Difference
(LSD) between the groups. 
RESULTS
Morphological studies: Morphological changes were
observed in B50 cells cultured under hypoxia when
compared to cells cultured in normoxia. The B50 cells in
hypoxia showed clustered groups of neuronal B50 cells,
evidence of degenerating, dying cells and already
degenerated and dead neuronal B50 cells. The normal
B50 neuronal cells cultured under normal incubator
showed normal neuronal morphology (Plate 1 and 2),
when compared to B50 cells in hypoxia (Plate 3 and 4).
The effect of hypoxia on the expression of Mu Opioid
receptor gene in B50 cells: The result of Mu receptor
gene expression in B50 neuronal cells in normal, hypoxic
and treated cells was studied using reverse transcription
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Plate 1: Representative of B50 cells at ohrs with normal B50
cells (arrow) at the point of starting the culture at 21%
O2 and 5% CO2. B50 cells were observed in three
different plates with same field method in a quadri-
point analysis under the Nikon Eclipse Eclipse TS
100 microscope and microphotographs processed
with an IBM Image Solution ®. Scale bar=5mm×40
magnification. 
Plate 2: Representative of B50 cells at 48hrs of normal cultural
(21%O2 and 5%Co2) with B50 cells (arrow). B50 cells
were observed in three different plates with same field
method in a quadri-point analysis under the Nikon
Eclipse TS 100 microscope and microphotographs
processed with IBM Image Solution®. Scale
bar=5mm×40 magnification. 
polymerase chain reaction (RT-PCR). (Fig. 1). The results
showed that the RT-PCR experiments with the B50
neuronal cells in normal, hypoxic and treated cultures
demonstrated positive gene expression of the Mu opioid
receptors. The mRNA levels of Mu opioid receptors in
hypoxic culture of B50 cells were expressed relative to
Mu opioid receptors in B50 cells cultured under normal
conditions, and these were also compared with mRNA
levels of Mu opioid receptors in hypoxic B50 cells treated
with different receptor agonists (Fig. 2). The results
showed  that  there  were no significant difference in the
Plate 3: Representative of hypoxic B50 cells at 48hrs of culture
(5% O2 and 5%CO2) with out drug administration,
showing groups of degenerating cells (arrow). Groups
of degeneration cells were observed in six different
plates with same field method in a quadri-point
analysis under the Nikon Eclipse Eclipse TS 100
microscope and microphotographs processed with an
IBM Image Solution ®. Scale bar=5mm×40
magnification. 
Plate 4: Representative of B50 cells in hypoxia at 96hrs at
96hrs of cultural (5% O2 and 5% Co2) with groups of
degenerating cells (arrow). B50 cells was observed in
six different plates with same field morphological
method in a quadri-point analysis under the Nikon
Eclipse TS 100 microscope and microphotographs
processed with an IBM Image Solution ®. Scale
bar=5mm×40 magnification. 
levels of mu opioid receptor gene and mRNA expression
between the normal, hypoxic and agonist treated cultured
B50 cells.
Semi quantitative RT-PCR of cannabinoid CB1 and
MOR:  MOR   expression   products   were  subjected  to
semi  quantitative   analysis   using   digital  densitometric
measurements.   The   decrease   in   the  density of MOR
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Table 1: Semi-Quantitative RT-PCR product of MOR receptors in B50 cells in culture
TreatmentType Vol.mm3 Areamm2 STD  ± Density Width Height Normal (%) Control (%)
MOR Normal 11.20 4.04 0.32 621.12 2.78 1.56 100 119.57
MORHypoxia 04.55 1.94 0.24 583.40 0.76 2.54 93.93 112.31
10:M DAMGO 14.57 5.90 0.35 613.07 2.73 2.16 98.70 118.02
50:MDAMGO 12.48 5.34 0.34 579.21 1.59 3.37 93.27 111.50
100:MDAMGO 10.61 4.29 0.35 613.22 1.78 2.41 98.73 118.05
DAMGO/CTAP 11.29 4.44 0.33 631.09 2.79 1.59 101.61 121.49
Alpha actin 10.35 3.22 0.32 519.46 2.02 3.12 86.63 100
Fig. 1: The effect og opioid treatment on MOR expression in cultured B50 cells in hypoxia, A = DNA Ladder; B = Normal cells;
C = Hypoxic cells; DEF = Hypoxic MOR treated; G = Alpha action
Fig. 2: The effect of hypoxia on the expression density of MOR receptor in B50 cells
RT-PCR products was not significant in untreated (MOR)
hypoxic cells (93%) and those treated with 10 :M
DAMGO (98%); 50 :M DAMGO and 100 :M DAMGO
(98%). There was no significant change in densitometric
measurements of mRNA area, mRNA volume, height and
width respectively when compared with the normal
control B50 cells (Table 1).
When the density of the RT-PCR products was
normalised to alpha actin (100%), there was no observed
difference in the level of the receptor mRNA expression
of MOR in normal, hypoxic and treated cultured B50
cells. The results showed no significant difference
between the normal MOR (119%); 10 :M DAMGO
(118%); 50 :M DAMGO (111%) and 100 :M DAMGO
(118%). 
Mu opioid (MOR) receptor expression in B50
neuronal cells in culture. Total RNA was extracted from
cultured B50 cells in normal (21% O2, 5% CO2), hypoxic
(5% O2, 5% CO2) and hypoxia treated with MOR
agonists. RT-PCR amplification was performed with
specific MOR primers. The gel was electrophoresed and
stained with ethidium bromide to visualise the intensity of
the cDNA for MOR (209 bp) and was normalised relative
to alpha actin (350 bp)
MOR receptor was expressed in B50 neuronal cells
in culture with total RNA extracted from B50 cells in
normal (21% O2, 5% CO2), hypoxic (5% O2, 5% CO2) and
hypoxia treated with MOR agonists. The RT-PCR was
amplified with specific MOR primers and gel was
electrophoresed and stained with ethidium bromide and
normalised relative to alpha actin. The RT-PCR product
was quantified with digital densitometer and expressed as
percent of control, (Data presented as mean ±SD;
Student’s t-test).
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MOR receptor was expressed in B50 neuronal cells in
culture with total RNA extracted from B50 cells in normal
(21% O2, 5% CO2), hypoxic (5% O2, 5% CO2) and hypoxia
treated with MOR agonists. The RT-PCR was amplified
with specific MOR primers and gel was electrophoresed
and stained with ethidium bromide and normalised
relative to alpha actin. The RT-PCR product was
quantified with digital densitometer and expressed as
percent of control, (Data presented as mean ±SD;
Student’s t-test)
DISCUSSION
The use of experimental approaches which include
morphological assessments, cell live and dead trypan
staining and viability and proliferation assay was used to
assess neuronal injury more directly from hypoxia. It has
been shown that during hypoxia, glutamate is expelled
from neurons leading to over-stimulation of glutamate
receptors and subsequent injury and death of the neurons
(Haddad and Jiang, 1993; Nyakas et al., 1996). Since
Zhang et al. (2002) had shown that because glutamate
receptor expression increases during development, and
sensitivity to glutamate excitotoxicity increases with
neuronal maturation, the observed differences in hypoxic
susceptibility between the neuronal ages in this study may
be associated with the developmental increase in
glutamate toxicity (Choi and Rothman, 1990).
This study has demonstrated that stimulation of
opioid receptors, proffers some protection by reducing
neuronal cell injuries and deaths after treatments in
hypoxic conditions but the benefit is reduced substantially
with prolonged exposure durations and higher
concentrations of the drugs. This supports the finding that
the longer the neurons stayed in the culture media both in
the normal and in the experimental hypoxic groups, the
greater the extent of the neuronal cell injuries and death.
A possible explanation for this phenomenon is that
prolonged hypoxia may cause a significant release and
accumulation of endogenous glutamate which causes
glutamate-induced toxicity and hence death of the cells
(Nyakas et al., 1996). Another alternative explanation is
that prolonged hypoxia causes the release and
accumulation of endogenous opioids which saturates
opioid receptors in these neurons. Hence the positive
effect of the opioid agonists decreases with the increase in
the time the cells stay in the medium which may result in
desensitization  of  the  receptors  and  the  reduced  effect
of   the  action  of  the  drugs  (Mao  et  al.,  2002;
Wallace et al., 2006). 
It has been shown that in response to short-term
hypoxia, the level of enkephalins, the endogenous
agonists  for  opioid  receptors  sharply increases (Zhang
et al., 2002; Khasabova et al., 2002). This showed that
cortical neurons may release opioids during normal
function and in response to hypoxic stress as a mechanism
of  self-protection  against  injury  (Ma et al., 2005;
Wallace et al., 2006). Zhang et al. (2002) showed that
because of high levels of endogenous opioids which may
already be present in the culture media after prolonged
exposure to hypoxia, adding more agonist may not
increase the protection by the drugs. On the other hand,
desensitization of the receptors may have occurred due to
prolonged treatment of the cells with the agonists in
conjunction with the endogenous opioid release during
chronic hypoxia. Zhang et al. (2006) have shown that
cortical neurons are highly susceptible to opioid receptor
inhibition, which causes serious neuronal injury especially
during hypoxic stress.
However, cellular injury was observed in cultured
B50 neurons than in both normoxic and hypoxic
conditions which suggests that maturational differences
exist between this age group of neurons. This supports the
work of Zhang et al. (2000), which showed that opioid
receptor expression increases significantly with
development in both brain and cultured neurons. This is
because the opioid receptor density increases with
increase in the age of the neurons though the result from
this present study shows that there was no difference in
the mu opioid receptor gene expression and no significant
change in the expression densities of the mu opioid
receptors. The more mature neurons may have greater
dependence on this pathway to maintain neuronal function
and therefore may be more susceptible to neuronal injury
with opioid receptor inhibition. This observation suggests
that the increase in opioid receptor agonist may compete
with opioid receptor antagonist in terms of opioid receptor
binding and thus reduce neuronal injury induced by opioid
receptor   inhibition   during   prolonged  hypoxia
(Wallace et al., 2006). This is in support of the findings in
this study in which at higher concentration of the agonists
and antagonist during the treatment against hypoxia, led
to complete inhibition of the agonists activities in cultured
B50 cells in hypoxia. 
Another issue is whether the differences in
expression levels of the various opioid receptors account
for the observed phenomenon in cortical neurons. Past
studies have demonstrated that :-opioid receptors are
present at similar or even higher densities than *-opioid
receptors in mammalian cortex, although 6-opioid
receptor density is slightly lower (Zhang et al., 2006).
This implies that the relative distribution and expression
levels of opioid receptor subtypes within the cortex as a
whole may not be a key factor in the observations shown
in this work. This is because the results presented in this
study show that there was no observed differences in the
receptor expression densities of :-opioid receptors in
normoxic, hypoxic and hypoxic treated B50 cells in
culture.
The mechanisms of opioid receptor neuroprotection
activity may involve the regulation of specific G proteins,
ion  channels mainly Ca2+ and K+ channels and excitatory
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neurotransmitter release. It has been shown that
intracellular Ca2+ levels are elevated during hypoxic
exposure leading to irreversible cell injury while the
inhibition of Ca2+ currents by opioid receptor stimulation
by DAMGO, DSLET and ICI-199441, may serve as a
neuroprotective mechanism in preventing Ca2+ overload
(Andersen, 2004; Bossy-Wetzel et al., 2004). Also opioid
receptor regulation of glutamate signalling may be
involved in normal function and protection of neurons
(Ma et al., 2005, Mao et al., 2002). It has also been shown
that opioid receptor agonists have the ability to reduce
neuronal over-stimulation by blocking glutamate
excitation (Zhang et al., 2002), and this could be the
situation with the protection proffered by the :-, *- and 6-
opioid agonists used in this study. This mechanism of
cellular regulation may be utilised during normal cell
functioning and in response to environmental stress like
hypoxia (Andersen, 2004). Zhang et al. (2006) have
shown that the inhibition of opioid receptors in normal
neurons may lead to substantial injury in the neurons by
the loss of inhibitory regulation of the excitatory
neurotransmitter  release and/or receptor excitation. The
*-, :- and 6-opioid receptors have many similarities such
as seven transmembrane domains existing as 60%
identical sequences and being coupled to Gi/o proteins.
Connor and Christie (1999) had proposed that because of
the common features of opioid receptors, the selectivity of
these receptors for eliciting specific pathways does not lie
in the differences between each opioid receptor subtype
but in their association with other divergent types of G
proteins. It was observed that each opioid receptor
subtype also preferentially couples to specific G proteins
apart from the Gi/o proteins that they generally couple
(Zhang et al., 2002). Examples of this preferential
coupling include as seen in *-opioid receptors which are
more efficiently coupled to G"16 protein than either µ- or
6-opioid receptors (Lee et al., 1998). Also µ-receptor
agonist (DAMGO) has been reported to have a selective
coupling to G"i1 and G"oA opioid receptors than other
opioid agonists (Saidak et al., 2006). This shows that the
opioid receptor agonists have selective activation of G-
proteins in response to opioid receptor activation. This
preferential coupling to other G protein subtypes may be
the reason for the observed differences in the effect of the
opioid agonists on the B50 cells treated in hypoxia. 
CONCLUSION
The results from the present study showed that
hypoxia induced morphological changes in B50 cells in
hypoxia while the Mu RT-PCR mRNA levels showed no
appreciable changes in normal, hypoxic and cells treated
with Mu opioid receptor agonists. The results show that
B50 neuronal cells are susceptible to damage and
injurious effects of hypoxia, as are most brain cells and
the Mu opioid receptor agonist treatments showed that
there were no changes in the level of Mu opioid receptor
gene expression due to hypoxia or agonist treatment in
neuronal B50 cells in culture.
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